Synergetics growth trends may be poised to rebound, says Benchmark Co. After Synergetics reported in-line Q1 EPS, Benchmark thinks the revenue of the company's previously weak Ophthalmic division appears to have stabilized. The firm expects the company's OEM business to continue to be strong and it maintains a Buy rating.
News For SURG From The Last 14 Days
Check below for free stories on SURG the last two weeks.
On The Fly: Analyst Upgrade Summary Today's noteworthy upgrades include: AmerisourceBergen (ABC) upgraded to Outperform from Market Perform at Leerink... Arthur J. Gallagher (AJG) upgraded to Buy from Neutral at Goldman... Catamaran (CTRX) upgraded to Buy from Neutral at UBS... Disney (DIS) upgraded to Outperform from Neutral at Macquarie... Fly Leasing (FLY) upgraded to Buy from Neutral at Citigroup... Navistar (NAV) upgraded to Market Perform from Underperform... Questcor (QCOR) upgraded to Buy from Fair Value at CRT Capital... Talisman Energy (TLM) upgraded to Buy from Hold at Tudor Pickering... Synergetics (SURG) upgraded to Buy from Hold at Craig-Hallum... RBC Bearings (ROLL) upgraded to Outperform from Market Perform at Barrington.